Publication | Closed Access

Antibody persistence of two pentavalent DTwP–HB–Hib vaccines to the age of 15–18 months, and response to the booster dose of quadrivalent DTwP–Hib vaccine

VaccinationVaccinologyCross-protectionVaccine DevelopmentAntibody PersistenceImmunodeficienciesImmunologyVaccine TestingImmunodominanceHumoral ImmunityT Cell ImmunityQuadrivalent Dtwp–hib VaccineBooster DoseVaccine DesignImmunotherapyMedicineVaccine Research